Inhibition of Inhibitor of Nuclear Factor-κB Phosphorylation Increases the Efficacy of Paclitaxel in <b> <i>in Vitro</i> </b> and <b> <i>in Vivo</i> </b> Ovarian Cancer Models

Seiji Mabuchi(Fox Chase Cancer Center), Yuji Murata(The University of Osaka)
Clinical Cancer Research
November 15, 2004
Cited by 114


Related Papers